Safe shortening of antibiotic treatment duration for complicated Staphylococcus aureus bacteraemia (SAFE trial): protocol for a randomised, controlled, open-label, non-inferiority trial comparing 4 and 6 weeks of antibiotic treatment

Autor: N Roescher, JM Prins, JTM van der Meer, HI Bax, R Soetekouw, MGJ de Boer, LBS Gelinck, JJ Oosterheert, MA van Agtmael, M Berrevoets, DTP Buis, CH van Werkhoven, MJM Bonten, JE Bosmans, J Branger, S Douiyeb, E Jong, AJJ Lammers, E Sieswerda, JE Stalenhoef, TW Van der Vaart, EA Bij de Vaate, NJ Verkaik, MGA Van Vonderen, PJ De Vries, KCE Sigaloff, E Botman, A Van den Broek, L Buitenhuis, E Buitenwerf, A S Cents, N Engels, J L J Hanssen, A J Meinders, F P N Mollema, L Nagelmaker, M L M van Doorn-Schepens, P Thomopoulos, M Timmer, B van der Wiel

Publikováno v: BMJ Open, Vol 13, Iss 4 (2023)

Introduction A major knowledge gap in the treatment of complicated Staphylococcus aureus bacteraemia (SAB) is the optimal duration of antibiotic therapy. Safe shortening of antibiotic therapy has the potential to reduce adverse drug events, length of

Externí odkaz: https://doaj.org/article/cf2fa20a75a4412a9dbd8b21a6ce2c68

Trends in Mortality in People With HIV From 1999 through 2020: A Multicohort Collaboration.

Autor: Tusch E; Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Ryom L; Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Department of Infectious Diseases, Hvidovre University Hospital, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Pelchen-Matthews A; Centre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, University College London, London, United Kingdom., Mocroft A; Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Centre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, University College London, London, United Kingdom., Elbirt D; Allergy, Immunology and HIV Unit, Kaplan Medical Center, Rehovot, Israel., Oprea C; HIV department, Victor Babes Clinical Hospital for Infectious and Tropical Diseases, Bucharest, Romania., Günthard HF; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Staehelin C; Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland., Zangerle R; Austrian HIV Cohort Study (AHIVCOS), Medizinische Universität Innsbruck, Innsbruck, Austria., Suarez I; Department I for Internal Medicine, University Hospital Cologne, Cologne, Germany., Vehreschild JJ; Department I for Internal Medicine, University Hospital Cologne, Cologne, Germany., Wit F; AIDS Therapy Evaluation in the Netherlands (ATHENA) Cohort, HIV Monitoring Foundation, Amsterdam, The Netherlands., Menozzi M; Modena HIV Cohort, Università degli Studi di Modena, Modena, Italy., d'Arminio Monforte A; Italian Cohort Naive Antiretrovirals (ICONA), ASST Santi Paolo e Carlo, Milano, Italy., Spagnuolo V; Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milano, Italy., Pradier C; Nice HIV Cohort, Université Côte d'Azur et Centre Hospitalier Universitaire, Nice, France., Carlander C; Swedish InfCare HIV Cohort, Karolinska University Hospital, Stockholm, Sweden., Suanzes P; Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Wasmuth JC; Infectious Diseases/HIV Department of the Medical Clinic I, University Hospital Bonn, Bonn, Germany., Carr A; HIV and Immunology Unit, St Vincent's Hospital, Sydney, New South Wales, Australia., Petoumenos K; Australian HIV Observational Database (AHOD), UNSW, Sydney, New South Wales, Australia., Borgans F; Department of Internal Medicine, Infectious Diseases, Frankfurt HIV Cohort Study, Goethe-University Hospital, University Hospital, Frankfurt, Germany., Bonnet F; Bordeaux Population Health Centre & CHU de Bordeaux, University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Saint-André Hospital, Service de Médecine Interne et Maladies Infectieuses, Bordeaux, Cedex, France., De Wit S; Department of Infectious Diseases, St Pierre University Hospital, Brussels, Belgium., El-Sadr W; Mailman School of Public Health, Columbia University, New York, New York, USA., Neesgaard B; Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Jaschinski N; Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Greenberg L; Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Hosein SR; European AIDS Treatment Group (EATG), Brussels, Belgium., Gallant J; Gilead Sciences, Foster City, California, USA., Vannappagari V; ViiV Healthcare, Research Triangle Park, North Carolina, USA., Young L; Merck Sharp & Dohme, Rahway, New Jersey, USA., Sabin C; Centre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, University College London, London, United Kingdom., Lundgren J; Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Peters L; Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Reekie J; Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Nov 22; Vol. 79 (5), pp. 1242-1257.

Infective Endocarditis After Transcatheter Versus Surgical Aortic Valve Replacement.

Autor: Panagides V; Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada., Cuervo G; Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain., Llopis J; Department of Genetics, Microbiology, and Statistics, University of Barcelona, Barcelona, Spain., Abdel-Wahab M; Heart Center Leipzig, University of Leipzig, Leipzig, Germany., Mangner N; Herzzentrum Dresden, Department of Internal Medicine and Cardiology, Technische Universität Dresden, Dresden, Germany., Habib G; Cardiology Department, Assistance Publique des Hôpitaux de Marseille, La Timone Hospital, Marseille, France., Regueiro A; Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain., Mestres CA; Department of Cardiac Surgery, University Hospital Zürich, Zurich, Switzerland., Tornos P; Department of Cardiology, Hospital Quiron Barcelona, Barcelona, Spain., Durand E; Department of Cardiology, Normandie University, CHU Rouen, France., Selton-Suty C; Department of Cardiology, University Hospital of Nancy, Nancy, France., Ihlemann N; Department of Cardiology, Righospitalet, Copenhagen, Denmark., Bruun N; Department of Cardiology, Zealand University Hospital, Roskilde, Denmark., Urena M; Cardiology Department, Bichat Hospital, Paris, France., Cecchi E; Cardiology Department, Hospital Maria Vittoria, Turin, Italy., Thiele H; Heart Center Leipzig, University of Leipzig, Leipzig, Germany., Durante-Mangoni E; Department of Precision Medicine, University of Campania 'L. Vanvitelli', Monaldi Hospital, Naples, Italy., Pellegrini C; Department of Cardiology, Deutsches Herzzentrum München, Munich, Germany., Eltchaninoff H; Department of Cardiology, Normandie University, CHU Rouen, France., Athan E; Department of Infectious Disease, Barwon Health, Deakin University, Geelong, Victoria, Australia., Søndergaard L; Department of Cardiology, Righospitalet, Copenhagen, Denmark., Linke A; Herzzentrum Dresden, Department of Internal Medicine and Cardiology, Technische Universität Dresden, Dresden, Germany., Tattevin P; Infectious Diseases and Intensive Care Unit, Pontchaillou University Hospital, Rennes, France., Del Val D; Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada., Quintana E; Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain., Chu V; Duke University School of Medicine, Durham, North Carolina, USA., Rodés-Cabau J; Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.; Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain., Miro JM; Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain.; CIBERINFEC, Instituto de Salud Carlos III, Madrid, Spain.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Jan 25; Vol. 78 (1), pp. 179-187.

An Internet-based self-help intervention for people with HIV and depressive symptoms: study protocol for a randomized controlled trial.

Autor: van Luenen, Sanne¹ s.van.luenen@fsw.leidenuniv.nl, Kraaij, Vivian¹, Spinhoven, Philip¹, Garnefski, Nadia¹

Publikováno v: Trials. 3/31/2016, Vol. 17, p1-12. 12p. 1 Diagram, 1 Chart.

Has the Rate of CD4 Cell Count Decline before Initiation of Antiretroviral Therapy Changed over the Course of the Dutch HIV Epidemic among MSM?

Autor: Gras, Luuk¹ l.a.gras@amc.uva.nl, Geskus, Ronald B.^2,3, Jurriaans, Suzanne⁴, Bakker, Margreet⁴, van Sighem, Ard¹, Bezemer, Daniela¹, Fraser, Christophe⁵, Prins, Jan M.⁶, Berkhout, Ben⁴

Publikováno v: PLoS ONE. May2013, Vol. 8 Issue 5, p1-8. 8p.